This weekly email delivers timely College news and a curated roundup of key articles and resources to keep you current, including breaking news, anecdotes from esteemed practitioners, insight into matters that affect the profession, and direct access to online education tools.
- Show all
- A Word from the President
- Annual Meeting
- Coding Conundrums
- Community Advantage
- Editorials from the Executive Medical Director
- High-five
- House of Delegates
- In Memoriam
- In My Opinion
- Medicare
- Practice Excellence
- Practice Management Advantage
- Spotlight on Annals
- Summation of COVID-19 Federal Responses
- Washington Perspectives
- Show all
- A/I Action
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- Committees
- COVID-19
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Member benefit
- New Allergists
- News
- Opinion
- Patient Brochures
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
May articles focus on natural history of tree nut allergy, special considerations for oral food challenges, and fatal food anaphylaxis
The last few months have been rough for all of us with the COVID-19 pandemic and the challenges it has presented to us, for personal and family safety as well …
Drug-induced anaphylaxis, mast cell activation syndrome and the ICON on ocular allergy
The days are getting longer as we get closer to the spring allergy season. Although our emphasis in this month’s issue of the Annals of Allergy, Asthma a…
February’s issue of Annals focuses on anaphylaxis
Groundhog Day came and went, and the little guy did not see his shadow, which means an early spring. Many of us are gearing up for the seasonal rush that we al…
Idiopathic anaphylaxis yardstick and biologics for asthma, plus interesting letters on diverse allergy topics
I hope your winter hasn’t been too harsh so far. The midsouth of the United States is having a milder than usual season, but there is still a great deal of moi…
Management of chronic urticaria, therapies for atopic dermatitis and the role of filaggrin in AD
Happy New Year! For many of us, 2019 absolutely flew by. As new information, new consensus and new guidelines continue to emerge, keeping up with w…
Spotlight on Annals
Christmas Day is right around the corner. Hopefully everyone (whether you personally celebrate Christmas or not) will have some down time coming with the new y…
A December issue focused on omics
Well, it is hard to believe that the year is drawing to a close. As we prepare for the holiday season, I hope you will have time to take a break and ponder wha…
Choosing the right biologic for severe patients, the continuum of worsening asthma and an exacerbation and treatment options for yellow zone patients
Next week many of us will gather in Houston for our Annual Meeting. There will be many learning opportunities, including great information on asthma. I thought…
Asthma management in children, viral infections and asthma and management of patients with asthma-COPD overlap
Well, we are all finally into the fall season in North America and there are signs of autumn everywhere ̶ even in the deep South where we have had amazingly …
Use of injectable epinephrine by a specific device, prevalence of CD163+ macrophages in lung tissue in fatal asthma patients, and an editorial on asthma therapy targeting macrophages
By now, all of you should have received your September issue of the Annals of Allergy, Asthma and Immunology. While our monthly emphasis has been in pharmacoec…